176 related articles for article (PubMed ID: 6614950)
1. Prognostic groups of patients with stage I melanoma.
Kuehnl-Petzoldt C; Wiebelt H; Berger H
Arch Dermatol; 1983 Oct; 119(10):816-9. PubMed ID: 6614950
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy and early-stage melanoma.
Daryanani D; Plukker JT; De Hullu JA; Kuiper H; Nap RE; Hoekstra HJ
Cancer; 2003 May; 97(9):2248-53. PubMed ID: 12712479
[TBL] [Abstract][Full Text] [Related]
4. Prognostic importance of the extent of ulceration in patients with clinically localized cutaneous melanoma.
In 't Hout FE; Haydu LE; Murali R; Bonenkamp JJ; Thompson JF; Scolyer RA
Ann Surg; 2012 Jun; 255(6):1165-70. PubMed ID: 22566014
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous melanomas that defy conventional prognostic indicators.
McCarthy WH; Shaw HM; McCarthy SW; Rivers JK; Thompson JF
Semin Oncol; 1996 Dec; 23(6):709-13. PubMed ID: 8970591
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of malignant melanoma.
Rigel DS; Rogers GS; Friedman RJ
Dermatol Clin; 1985 Apr; 3(2):309-14. PubMed ID: 3830493
[TBL] [Abstract][Full Text] [Related]
7. Invasive cutaneous melanoma in elderly patients.
Loggie B; Ronan SG; Bean J; Das Gupta TK
Arch Dermatol; 1991 Aug; 127(8):1188-93. PubMed ID: 1863077
[TBL] [Abstract][Full Text] [Related]
8. Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.
Sahin S; Rao B; Kopf AW; Lee E; Rigel DS; Nossa R; Rahman IJ; Wortzel H; Marghoob AA; Bart RS
Cancer; 1997 Oct; 80(8):1426-31. PubMed ID: 9338466
[TBL] [Abstract][Full Text] [Related]
9. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
[TBL] [Abstract][Full Text] [Related]
10. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit.
McKinnon JG; Yu XQ; McCarthy WH; Thompson JF
Cancer; 2003 Sep; 98(6):1223-31. PubMed ID: 12973846
[TBL] [Abstract][Full Text] [Related]
11. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
[TBL] [Abstract][Full Text] [Related]
12. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
13. Endogenous immune response to early- and intermediate-stage melanoma is correlated with outcomes and is independent of locoregional relapse and standard prognostic factors.
Litvak DA; Gupta RK; Yee R; Wanek LA; Ye W; Morton DL
J Am Coll Surg; 2004 Jan; 198(1):27-35. PubMed ID: 14698308
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of ulceration of cutaneous melanoma.
Balch CM; Wilkerson JA; Murad TM; Soong SJ; Ingalls AL; Maddox WA
Cancer; 1980 Jun; 45(12):3012-7. PubMed ID: 7388745
[TBL] [Abstract][Full Text] [Related]
15. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
Gimotty PA; Elder DE; Fraker DL; Botbyl J; Sellers K; Elenitsas R; Ming ME; Schuchter L; Spitz FR; Czerniecki BJ; Guerry D
J Clin Oncol; 2007 Mar; 25(9):1129-34. PubMed ID: 17369575
[TBL] [Abstract][Full Text] [Related]
16. Classification of localized melanoma by the exponential survival trees method.
Huang X; Soong S; McCarthy WH; Urist MM; Balch CM
Cancer; 1997 Mar; 79(6):1122-8. PubMed ID: 9070489
[TBL] [Abstract][Full Text] [Related]
17. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
[TBL] [Abstract][Full Text] [Related]
18. Is ulceration in cutaneous melanoma just a prognostic and predictive factor or is ulcerated melanoma a distinct biologic entity?
Eggermont AM; Spatz A; Lazar V; Robert C
Curr Opin Oncol; 2012 Mar; 24(2):137-40. PubMed ID: 22234255
[TBL] [Abstract][Full Text] [Related]
19. Enhanced survival in patients with multiple primary melanoma.
Doubrovsky A; Menzies SW
Arch Dermatol; 2003 Aug; 139(8):1013-8. PubMed ID: 12925389
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in patients with thick cutaneous melanoma (> 4 mm).
Zettersten E; Sagebiel RW; Miller JR; Tallapureddy S; Leong SP; Kashani-Sabet M
Cancer; 2002 Feb; 94(4):1049-56. PubMed ID: 11920475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]